Logo image of BRBR

BELLRING BRANDS INC (BRBR) Stock Fundamental Analysis

USA - NYSE:BRBR - US07831C1036 - Common Stock

36.63 USD
-0.12 (-0.33%)
Last: 9/17/2025, 7:00:00 PM
36.63 USD
0 (0%)
After Hours: 9/17/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BRBR. BRBR was compared to 36 industry peers in the Personal Care Products industry. BRBR has an excellent profitability rating, but there are some minor concerns on its financial health. BRBR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BRBR had positive earnings in the past year.
BRBR had a positive operating cash flow in the past year.
In the past 5 years BRBR has always been profitable.
Each year in the past 5 years BRBR had a positive operating cash flow.
BRBR Yearly Net Income VS EBIT VS OCF VS FCFBRBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

BRBR has a better Return On Assets (22.97%) than 100.00% of its industry peers.
BRBR's Return On Invested Capital of 39.15% is amongst the best of the industry. BRBR outperforms 100.00% of its industry peers.
BRBR had an Average Return On Invested Capital over the past 3 years of 38.65%. This is significantly above the industry average of 12.97%.
The 3 year average ROIC (38.65%) for BRBR is below the current ROIC(39.15%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 22.97%
ROE N/A
ROIC 39.15%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
BRBR Yearly ROA, ROE, ROICBRBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

With an excellent Profit Margin value of 10.26%, BRBR belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Profit Margin of BRBR has declined.
BRBR has a better Operating Margin (16.51%) than 83.33% of its industry peers.
In the last couple of years the Operating Margin of BRBR has remained more or less at the same level.
With a Gross Margin value of 35.43%, BRBR is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BRBR has remained more or less at the same level.
Industry RankSector Rank
OM 16.51%
PM (TTM) 10.26%
GM 35.43%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
BRBR Yearly Profit, Operating, Gross MarginsBRBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRBR is creating value.
The number of shares outstanding for BRBR has been reduced compared to 1 year ago.
BRBR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BRBR has been reduced compared to a year ago.
BRBR Yearly Shares OutstandingBRBR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRBR Yearly Total Debt VS Total AssetsBRBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 6.43 indicates that BRBR is not in any danger for bankruptcy at the moment.
BRBR's Altman-Z score of 6.43 is amongst the best of the industry. BRBR outperforms 86.11% of its industry peers.
BRBR has a debt to FCF ratio of 7.96. This is a slightly negative value and a sign of low solvency as BRBR would need 7.96 years to pay back of all of its debts.
BRBR has a better Debt to FCF ratio (7.96) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.96
Altman-Z 6.43
ROIC/WACC4.8
WACC8.15%
BRBR Yearly LT Debt VS Equity VS FCFBRBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

2.3 Liquidity

BRBR has a Current Ratio of 2.55. This indicates that BRBR is financially healthy and has no problem in meeting its short term obligations.
BRBR has a better Current ratio (2.55) than 66.67% of its industry peers.
BRBR has a Quick Ratio of 1.12. This is a normal value and indicates that BRBR is financially healthy and should not expect problems in meeting its short term obligations.
BRBR has a Quick ratio (1.12) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 1.12
BRBR Yearly Current Assets VS Current LiabilitesBRBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.58% over the past year.
Measured over the past years, BRBR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.29% on average per year.
Looking at the last year, BRBR shows a quite strong growth in Revenue. The Revenue has grown by 16.27% in the last year.
The Revenue has been growing by 18.50% on average over the past years. This is quite good.
EPS 1Y (TTM)18.58%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%1.85%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%6.23%

3.2 Future

Based on estimates for the next years, BRBR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.48% on average per year.
BRBR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.36% yearly.
EPS Next Y16.76%
EPS Next 2Y11.34%
EPS Next 3Y11.99%
EPS Next 5Y10.48%
Revenue Next Year16%
Revenue Next 2Y12.83%
Revenue Next 3Y11.55%
Revenue Next 5Y8.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRBR Yearly Revenue VS EstimatesBRBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
BRBR Yearly EPS VS EstimatesBRBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.88, which indicates a correct valuation of BRBR.
Based on the Price/Earnings ratio, BRBR is valued cheaper than 80.56% of the companies in the same industry.
BRBR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
Based on the Price/Forward Earnings ratio of 15.31, the valuation of BRBR can be described as correct.
77.78% of the companies in the same industry are more expensive than BRBR, based on the Price/Forward Earnings ratio.
BRBR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.88
Fwd PE 15.31
BRBR Price Earnings VS Forward Price EarningsBRBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRBR indicates a somewhat cheap valuation: BRBR is cheaper than 61.11% of the companies listed in the same industry.
61.11% of the companies in the same industry are more expensive than BRBR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 36.42
EV/EBITDA 14.5
BRBR Per share dataBRBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BRBR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y11.34%
EPS Next 3Y11.99%

0

5. Dividend

5.1 Amount

BRBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BELLRING BRANDS INC

NYSE:BRBR (9/17/2025, 7:00:00 PM)

After market: 36.63 0 (0%)

36.63

-0.12 (-0.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-18 2025-11-18/amc
Inst Owners100.93%
Inst Owner Change2.05%
Ins Owners1.28%
Ins Owner Change-0.21%
Market Cap4.61B
Analysts83.48
Price Target57.39 (56.67%)
Short Float %4%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.74%
Min EPS beat(2)-0.84%
Max EPS beat(2)8.31%
EPS beat(4)3
Avg EPS beat(4)6.72%
Min EPS beat(4)-0.84%
Max EPS beat(4)18.96%
EPS beat(8)7
Avg EPS beat(8)11.06%
EPS beat(12)11
Avg EPS beat(12)10.83%
EPS beat(16)14
Avg EPS beat(16)11.54%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-0.33%
Max Revenue beat(2)1.03%
Revenue beat(4)2
Avg Revenue beat(4)0.46%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)1.64%
Revenue beat(8)5
Avg Revenue beat(8)1.26%
Revenue beat(12)7
Avg Revenue beat(12)0.65%
Revenue beat(16)8
Avg Revenue beat(16)-0.21%
PT rev (1m)-27.55%
PT rev (3m)-28.78%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)-8.54%
EPS NY rev (1m)0.46%
EPS NY rev (3m)0.62%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-2.3%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 16.88
Fwd PE 15.31
P/S 2.07
P/FCF 36.42
P/OCF 35.07
P/B N/A
P/tB N/A
EV/EBITDA 14.5
EPS(TTM)2.17
EY5.92%
EPS(NY)2.39
Fwd EY6.53%
FCF(TTM)1.01
FCFY2.75%
OCF(TTM)1.04
OCFY2.85%
SpS17.66
BVpS-2.46
TBVpS-4.01
PEG (NY)1.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 22.97%
ROE N/A
ROCE 52.23%
ROIC 39.15%
ROICexc 41.74%
ROICexgc 59.28%
OM 16.51%
PM (TTM) 10.26%
GM 35.43%
FCFM 5.7%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score5
Asset Turnover2.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.96
Debt/EBITDA 2.62
Cap/Depr 26.49%
Cap/Sales 0.22%
Interest Coverage 250
Cash Conversion 34.11%
Profit Quality 55.5%
Current Ratio 2.55
Quick Ratio 1.12
Altman-Z 6.43
F-Score5
WACC8.15%
ROIC/WACC4.8
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)18.58%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%1.85%
EPS Next Y16.76%
EPS Next 2Y11.34%
EPS Next 3Y11.99%
EPS Next 5Y10.48%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%6.23%
Revenue Next Year16%
Revenue Next 2Y12.83%
Revenue Next 3Y11.55%
Revenue Next 5Y8.36%
EBIT growth 1Y3.85%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year23.76%
EBIT Next 3Y15.36%
EBIT Next 5Y9.6%
FCF growth 1Y-8.65%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y-6.2%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%